MTX sodium

Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.

Molecular Formula: C₂₀H₂₁N₈NaO₅

InChI: InChI=1/C20H22N8O5.Na/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);/q;+1/p-1/fC20H21N8O5.Na/h25,32H,21-22H2;/q-1;m

InChIKey: InChIKey=BKBBTCORRZMASO-IZJFISDUCI
SMILES: CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)O.[Na+]

Names:
    EINECS 239-495-5
    Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, sodium salt
    Methotrexate sodium (x-Na)
    METHOTREXATE SODIUM
    Methotrexate sodium salt
    MTX sodium
    Sodium L-(+)-methotrexate
    Sodium N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamate
    sodium 4-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]-5-hydroxy-5-oxo-pentanoate
    15475-56-6
    59-05-2

Registries:
    PubChem CID 61796
    PubChem ID 198187